The study by Klampfl et al., which was mainly performed by Sanger sequencing and fragment analysis, included 311 ET patients and 203 patients with PMF showing higher platelet counts and lower leukocyte levels in CALR mutated patients in both cohorts together with lower hemoglobin in ET. The gene discussed is CALR; the disease is essential thrombocythemia.